drugset / Trial / NCT02209454
Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to compare the bioavailability of 25 mg DKP.TRIS given as an Enantyum® oral solution (Test formulation) and Keral® tablet (Reference formulation). In addition, this study intends to evaluate the safety and tolerability of Test and Reference formulations.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-05
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexketoprofen Trometamol | Small molecule | 25 mg | Oral |
Indications
No indication recorded.